Addex Therapeutics Ltd
- ADXN
- NASDAQ
- Biotechnology
- CNS Drug Development
- Allosteric Modulator Drugs
$2.76
Today −8.61%Quote Oct 16, 2026, 08:00 PM UTC
−17.86%over the last month
Max drawdown −27.4%From 1-month high −24.4%3 months −50.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$408.0M
Quote Oct 16
Next earnings
Nov 9
Expected, not confirmed
Analyst target
$30.00
+987.0% from here
Floor
$2.65
4.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ADXNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
3
Founded
2002